What is Indivior PLC (IZQVF)?

Indivior PLC (IZQVF) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of IZQVF?

The current price of IZQVF is $20.97. Prices are updated in real time on Stocks360.

What is IZQVF's market capitalization?

IZQVF's market capitalization is $2,891,322,798.00, placing it in the mid-cap tier.

Indivior PLC (IZQVF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$20.97

Market Cap

$2.89B

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-0.06

Day Range

$20.97 – $20.97

52-wk Range

$15.00 – $26.50

Avg Volume

N/A

Volume

530.00

Indivior PLC (IZQVF) is a publicly traded company in the Healthcare sector. Latest price: $20.97. Market cap $2.89B. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Nov 1, 2018

EPS $0.12 vs est. $0.05

Beat by $0.07

Proprietary Signals

Signal snapshot temporarily unavailable.

About Indivior PLC

Indivior PLC, along with its various associated companies, focuses on the creation, production, and distribution of buprenorphine-derived prescription pharmaceuticals. These medications are primarily utilized in the management of opioid addiction and concurrent mental health disorders. The firm's ongoing product development initiatives are geared towards advancing therapies for opioid use disorder, other forms of addiction, and schizophrenia. Among its prominent offerings, Indivior actively commercializes SUBLOCADE, an injectable treatment administered subcutaneously, and a range of sublingual formulations, including SUBOXONE (available as both a film and a tablet) and SUBUTEX (a tablet). The company also continues to sell established legacy products such as Temgesic, Burpex, and Buprenex. With a global presence, Indivior PLC operates in roughly 40 countries worldwide. The company maintains a research partnership with Addex Therapeutics Ltd. Founded in 2014, Indivior PLC's main corporate office is located in North Chesterfield, Virginia.